Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PROTEIN CHARACTERIZATION INSTRUMENT INDUSTRY
2.1 Summary about Protein Characterization Instrument Industry
2.2 Protein Characterization Instrument Market Trends
2.2.1 Protein Characterization Instrument Production & Consumption Trends
2.2.2 Protein Characterization Instrument Demand Structure Trends
2.3 Protein Characterization Instrument Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Chromatography Instruments
4.2.2 Electrophoresis Instruments
4.2.3 Label-free Detection Instruments
4.2.4 Mass Spectrometery
4.2.5 Spectroscopy Instruments
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Clinical Diagnosis
4.3.2 Drug Discovery and Development
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Chromatography Instruments
5.2.2 Electrophoresis Instruments
5.2.3 Label-free Detection Instruments
5.2.4 Mass Spectrometery
5.2.5 Spectroscopy Instruments
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Clinical Diagnosis
5.3.2 Drug Discovery and Development
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Chromatography Instruments
6.2.2 Electrophoresis Instruments
6.2.3 Label-free Detection Instruments
6.2.4 Mass Spectrometery
6.2.5 Spectroscopy Instruments
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Clinical Diagnosis
6.3.2 Drug Discovery and Development
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Chromatography Instruments
7.2.2 Electrophoresis Instruments
7.2.3 Label-free Detection Instruments
7.2.4 Mass Spectrometery
7.2.5 Spectroscopy Instruments
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Clinical Diagnosis
7.3.2 Drug Discovery and Development
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Chromatography Instruments
8.2.2 Electrophoresis Instruments
8.2.3 Label-free Detection Instruments
8.2.4 Mass Spectrometery
8.2.5 Spectroscopy Instruments
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Clinical Diagnosis
8.3.2 Drug Discovery and Development
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Chromatography Instruments
9.2.2 Electrophoresis Instruments
9.2.3 Label-free Detection Instruments
9.2.4 Mass Spectrometery
9.2.5 Spectroscopy Instruments
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Clinical Diagnosis
9.3.2 Drug Discovery and Development
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Agilent Technologies (U.S.)
10.1.2 Bio-Rad Laboratories, Inc. (U.S.)
10.1.3 Bruker Corp. (U.S.)
10.1.4 Danaher Corp. (U.S.)
10.1.5 GE Healthcare (U.K.)
10.1.6 Perkin Elmer (U.S.)
10.1.7 Shimadzu Corp. (Japan)
10.1.8 Sigma-Aldrich Corp. (U.S.)
10.1.9 Thermo Fisher Scientific (U.S.)
10.1.10 Waters Corp. (U.S)
10.2 Protein Characterization Instrument Sales Date of Major Players (2017-2020e)
10.2.1 Agilent Technologies (U.S.)
10.2.2 Bio-Rad Laboratories, Inc. (U.S.)
10.2.3 Bruker Corp. (U.S.)
10.2.4 Danaher Corp. (U.S.)
10.2.5 GE Healthcare (U.K.)
10.2.6 Perkin Elmer (U.S.)
10.2.7 Shimadzu Corp. (Japan)
10.2.8 Sigma-Aldrich Corp. (U.S.)
10.2.9 Thermo Fisher Scientific (U.S.)
10.2.10 Waters Corp. (U.S)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
